potential drug combinations
drug combination hits
drug combination prediction
emergence of drug resistance
rational selection of personalized cancer drug combinations
multi-targeted drug combinations
drug combination screen data
cancer treatment
cancer patients
preclinical drug testing platform
underlying drug target interactions
individual patient samples
ovarian cancer samples
cancer cells
personalized strategies
identification of patient subgroups
patient-derived leukaemia
acquired resistance
effective therapeutic strategies
rapid development of resistance
selective efficacy
limited efficacy
sample subgroups
treatment options
Informatics approaches
clinical trials
clinical collaborators
line chemotherapy
patients resistant
pharmacological screening data
network modelling approaches
significant synergy
grand challenges
clustering methods
computational tools
molecular profiling
health care system
signalling networks
project
relevant doses
novel
mechanisms
drugs